PSD-93 mediates the crosstalk between neuron and microglia and facilitates acute ischemic stroke injury by binding to CX3CL1.
Qingxiu ZhangLei HeMo ChenHui YangXiaowei CaoXiaomei LiuQi HaoZhengwei ChenTengfei LiuXiu-E WeiLiangqun RongPublished in: Journal of neurochemistry (2021)
Post-synaptic density 93 (PSD-93) mediates glutamate excitotoxicity induced by ischemic brain injury, which then induces microglial inflammatory response. However, the underlying mechanisms of how PSD-93 mediates the crosstalk between neurons and microglia in the post-synaptic dense region remain elusive. CX3 chemokine ligand 1 (CX3CL1) is a chemokine specifically expressed in neurons while its receptor CX3CR1 is highly expressed in microglia. In this study, we examined the interaction of PSD-93 and CX3CL1 in the crosstalk between neurons and microglia in acute ischemic stroke. We utilized male C57BL/6 mice to establish the middle cerebral artery occlusion model (MCAO) and designed a fusion small peptide Tat-CX3CL1 (357-395aa) to inhibit PSD-93 and CX3CL1 interaction. The combination peaks of PSD-93 and CX3CL1 at 6 hr after I/R were observed. The binding sites were located at the 420-535 amino acid sequence of PSD-93 and 357-395 amino acid sequence of CX3CL1. Tat-CX3CL1 (357-395aa) could inhibit the interaction of PSD-93 and CX3CL1 and inhibited the pro-inflammatory cytokine IL-1β and TNF-α expression and provided neuroprotection following reperfusion. Together, these data suggest that PSD-93 binds CX3CL1 to activate microglia and initiate neuroinflammation. Specific blockade of PSD-93-CX3CL1 interaction reduces I/R induced neuronal cell death, and provides a new therapeutic target for ischemic stroke.
Keyphrases
- inflammatory response
- brain injury
- acute ischemic stroke
- cerebral ischemia
- neuropathic pain
- amino acid
- cell death
- spinal cord
- lipopolysaccharide induced
- middle cerebral artery
- subarachnoid hemorrhage
- acute myocardial infarction
- machine learning
- traumatic brain injury
- acute coronary syndrome
- metabolic syndrome
- cell proliferation
- poor prognosis
- endothelial cells
- big data
- insulin resistance
- binding protein
- electronic health record
- coronary artery disease